
Last update at 2026-03-10T20:21:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
3 Consumer Stocks with Mounting Challenges
Thu 01 May 25, 04:35 AM3 Cash-Heavy Stocks in the Doghouse
Mon 28 Apr 25, 01:09 PMNature's Sunshine Wins Two Stevie® Awards in the 2025 American Business Awards®
Thu 24 Apr 25, 05:52 PMPersonal Care Stocks Q4 Results: Benchmarking Medifast (NYSE:MED)
Thu 10 Apr 25, 09:07 AMQ4 Earnings Highs And Lows: Coty (NYSE:COTY) Vs The Rest Of The Personal Care Stocks
Mon 17 Mar 25, 09:04 AMNature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results
Tue 11 Mar 25, 08:05 PMNature’s Sunshine Launches First Integrated Brand Platform
Mon 03 Mar 25, 07:36 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 15.21M | 31.82M | 22.82M | 15.64M | 3.20M |
| Minority interest | 0.94M | 1.35M | 1.62M | 0.16M | -0.34800M |
| Net income | 0.55M | 28.85M | 21.34M | 6.76M | -0.85400M |
| Selling general administrative | 153.12M | 154.10M | 131.30M | 128.74M | 138.43M |
| Selling and marketing expenses | 130.38M | 139.84M | 131.15M | 123.41M | 125.34M |
| Gross profit | 299.76M | 328.62M | 283.93M | 268.27M | 269.12M |
| Reconciled depreciation | 11.03M | 11.16M | 10.74M | 10.60M | 9.81M |
| Ebit | 16.26M | 34.67M | 21.48M | 16.12M | 5.35M |
| Ebitda | 27.28M | 45.83M | 32.23M | 26.72M | 15.16M |
| Depreciation and amortization | 11.03M | 11.16M | 10.74M | 10.60M | 9.81M |
| Non operating income net other | -1.04300M | -2.84800M | 1.34M | -0.48300M | -2.15100M |
| Operating income | 16.26M | 34.67M | 21.48M | 16.12M | 5.35M |
| Other operating expenses | 405.65M | 409.41M | 363.72M | 346.09M | 359.46M |
| Interest expense | 0.25M | 0.25M | 0.10M | 0.04M | 0.39M |
| Tax provision | 14.66M | 1.61M | -0.13700M | 8.71M | 4.40M |
| Interest income | 0.12M | 0.47M | 0.17M | 0.26M | 0.07M |
| Net interest income | -0.12600M | 0.22M | 0.07M | 0.22M | -0.38700M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 14.66M | 1.61M | -0.13700M | 8.71M | 4.40M |
| Total revenue | 421.91M | 444.08M | 385.20M | 362.21M | 364.81M |
| Total operating expenses | 283.50M | 293.95M | 262.45M | 252.15M | 263.77M |
| Cost of revenue | 122.15M | 115.47M | 101.28M | 93.94M | 95.69M |
| Total other income expense net | -1.04300M | -2.84800M | 1.34M | -0.48300M | -2.15100M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 0.55M | 30.21M | 22.96M | 6.93M | -1.20200M |
| Net income applicable to common shares | -0.39000M | 28.85M | 21.34M | 6.76M | -0.85400M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 249.77M | 229.78M | 258.87M | 249.50M | 213.07M |
| Intangible assets | - | 1.54M | - | - | 0.57M |
| Earning assets | - | - | - | - | - |
| Other current assets | 7.72M | 7.42M | 8.76M | 6.94M | 5.09M |
| Total liab | 90.23M | 82.73M | 97.47M | 92.26M | 83.63M |
| Total stockholder equity | 154.06M | 142.91M | 158.20M | 155.39M | 129.21M |
| Deferred long term liab | - | 2.14M | 2.53M | - | - |
| Other current liab | 62.50M | 51.54M | 57.38M | 53.58M | 45.82M |
| Common stock | 119.69M | 121.58M | 133.38M | 139.31M | 135.74M |
| Capital stock | 119.69M | 121.58M | 133.38M | 139.31M | 135.74M |
| Retained earnings | 49.71M | 34.63M | 35.02M | 26.03M | 4.69M |
| Other liab | - | 3.40M | 3.71M | 3.78M | 5.47M |
| Good will | - | - | - | - | - |
| Other assets | 0.00000M | 17.96M | 25.00M | 20.87M | 16.33M |
| Cash | 82.37M | 60.03M | 86.18M | 92.07M | 53.63M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 76.75M | 65.58M | 76.67M | 69.65M | 57.95M |
| Current deferred revenue | 1.79M | 2.25M | 3.69M | 2.09M | 1.27M |
| Net debt | -67.45000M | -40.84700M | -63.19500M | -65.74100M | -26.95700M |
| Short term debt | 4.55M | 5.44M | 5.90M | 7.50M | 6.46M |
| Short long term debt | - | 1.17M | 1.55M | 2.51M | 1.52M |
| Short long term debt total | 14.92M | 19.18M | 22.99M | 26.33M | 26.67M |
| Other stockholder equity | 5.48M | 4.14M | 3.20M | 157.23M | 129.44M |
| Property plant equipment | - | 46.16M | 50.86M | 54.35M | 59.51M |
| Total current assets | 165.82M | 149.51M | 164.67M | 154.06M | 112.70M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | 142.91M | 158.20M | 155.39M | 128.64M |
| Short term investments | - | 3.86M | - | 0.99M | - |
| Net receivables | 8.83M | 14.11M | 8.87M | 7.38M | 7.32M |
| Long term debt | - | - | 1.17M | 2.42M | - |
| Inventory | 66.89M | 67.95M | 60.85M | 47.68M | 46.67M |
| Accounts payable | 7.91M | 6.35M | 9.70M | 6.49M | 4.41M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | 4.14M | 3.20M | 1.85M | 0.23M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -15.34700M | -13.31300M | -10.20500M | -9.95500M | -11.22500M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 121.58M | 133.38M | 139.31M | 135.74M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 34.63M | 35.02M | 26.03M | 4.69M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 9.78M | 10.40M | 11.41M | 12.18M | 11.43M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 83.96M | 80.27M | 94.21M | 95.43M | 100.36M |
| Capital lease obligations | 14.92M | 18.01M | 20.27M | 21.40M | 25.15M |
| Long term debt total | - | - | 1.17M | 2.42M | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -7.62800M | -6.61200M | -4.90500M | -5.10200M | 0.21M |
| Change to liabilities | -6.98500M | 3.09M | 8.10M | -11.51300M | 12.38M |
| Total cashflows from investing activities | -7.62800M | -6.61200M | -4.90500M | -5.10200M | 0.21M |
| Net borrowings | -1.54600M | -2.20300M | 3.41M | 3.41M | -12.18100M |
| Total cash from financing activities | -16.24600M | -31.72100M | 3.88M | -0.06300M | -12.19200M |
| Change to operating activities | -10.14200M | -2.81600M | -1.27900M | -13.64900M | 11.13M |
| Net income | 0.55M | 30.21M | 22.96M | 6.93M | -1.20200M |
| Change in cash | -26.15200M | -5.88500M | 38.44M | 2.99M | 7.73M |
| Begin period cash flow | 86.18M | 92.07M | 53.63M | 50.64M | 42.91M |
| End period cash flow | 60.03M | 86.18M | 92.07M | 53.63M | 50.64M |
| Total cash from operating activities | 0.71M | 34.61M | 37.66M | 8.54M | 21.83M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 11.03M | 11.16M | 10.74M | 10.60M | 9.81M |
| Other cashflows from investing activities | - | 0.05M | - | 0.00200M | 5.04M |
| Dividends paid | 3.10M | -19.85800M | 19.86M | 19.86M | 19.86M |
| Change to inventory | -8.84100M | -14.45600M | -0.15400M | -4.87000M | 1.07M |
| Change to account receivables | -5.94200M | -1.68100M | 0.11M | 0.38M | 0.19M |
| Sale purchase of stock | -13.57100M | -7.42500M | - | 0.26M | 0.66M |
| Other cashflows from financing activities | 43.88M | -2.23500M | 9.57M | 2.00M | 69.31M |
| Change to netincome | 4.80M | 6.56M | 2.28M | 2.41M | -0.05700M |
| Capital expenditures | 7.63M | 6.67M | 4.91M | 5.10M | 4.83M |
| Change receivables | -5.94200M | -1.68100M | 0.11M | 0.38M | 0.19M |
| Cash flows other operating | 6.11M | -0.27100M | -6.38000M | 4.61M | -0.34600M |
| Exchange rate changes | - | - | - | - | -2.12400M |
| Cash and cash equivalents changes | -23.16400M | -3.72500M | 36.63M | 3.38M | 7.73M |
| Change in working capital | -27.31900M | -14.74000M | 0.79M | -21.68800M | 11.86M |
| Stock based compensation | 2.90M | 3.73M | 3.79M | 2.12M | 2.17M |
| Other non cash items | 6.95M | 8.38M | 3.73M | 6.31M | -0.77800M |
| Free cash flow | -6.91800M | 27.94M | 32.75M | 3.44M | 17.00M |
Sector: Consumer Defensive Industry: Packaged Foods
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NATR Natures Sunshine Products Inc |
-0.05 0.20% | 25.08 | 18.14 | - | 0.80 | 2.32 | 0.65 | 9.06 |
| NSRGF Nestle SA |
-0.88 0.85% | 102.12 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-1.86 1.79% | 101.81 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| KHC Kraft Heinz Co |
-0.78 3.19% | 23.66 | 15.59 | 11.79 | 1.64 | 0.88 | 2.34 | 11.32 |
| DANOY Danone PK |
-0.14 0.87% | 16.00 | 28.42 | 16.39 | 1.44 | 2.23 | 1.85 | 12.41 |
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
2901 West Bluegrass Boulevard, Lehi, UT, United States, 84043
| Name | Title | Year Born |
|---|---|---|
| Mr. Terrence O. Moorehead | Pres, CEO & Director | 1963 |
| Mr. Daniel C. Norman | Exec. VP & Pres of Asia/Pacific (APAC) | 1974 |
| Mr. Jonathan D. Lanoy | Interim CFO, Principal Financial & Accounting officer and Corp. Controller | 1975 |
| Trent McCausland | Exec. Director, Head of Operations & COO | NA |
| Mr. Nathan G. Brower | Exec. VP, Gen. Counsel & Sec. | 1980 |
| Ms. Tracee Comstock | VP of HR | 1966 |
| Mr. Bryant J. Yates | Exec. VP & Pres of Europe | 1973 |
| Ms. Lynda Marie Hammons | Sr. VP of Global Quality & Regulatory Affairs | 1955 |
| Mr. Richard Zhang | Managing Director of China | NA |
| Mr. Henry Zhou | Managing Director of China for Synergy | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.